Potential neuroprotective effect of Anakinra in spinal cord injury in an in vivo experimental animal model

References

1. ↵
   1. Genovese T,
   2. Mazzon E,
   3. Crisafulli C,
   4. Di Paola R,
   5. Muià C,
   6. Bramanti P,
   7. et al.

   (2006) Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 316, 1006–1016.
2. ↵
   1. Hooshmand MJ,
   2. Galvan MD,
   3. Partida E,
   4. Anderson AJ

   (2014) Characterization of recovery, repair, and inflammatory processes following contusion spinal cord injury in old female rats: is age a limitation? Immun Ageing 11, 15.
3. ↵
   1. Hayashi M,
   2. Ueyama T,
   3. Nemoto K,
   4. Tamaki T,
   5. Senba E

   (2000) Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma 17, 203–218.
4. ↵
   1. Courcoul A,
   2. Vignot E,
   3. Chapurlat R

   (2014) Successful treatment of Erdheim-Chester disease by interleukin-1 receptor antagonist protein. Joint Bone Spine 81, 175–177.
5. ↵
   1. Nandi P,
   2. Kingsley GH,
   3. Scott DL

   (2008) Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis. Curr Opin Rheumatol 20, 251–256.
6. ↵
   1. Ljubisavljevic S,
   2. Stojanovic I,
   3. Cvetkovic T,
   4. Vojinovic S,
   5. Stojanov D,
   6. Stojanovic D,
   7. et al.

   (2014) Glutathione homeostasis disruption of erythrocytes, but not glutathione peroxidase activity change, is closely accompanied with neurological and radiological scoring of acute CNS inflammation. Neuroimmunomodulation 21, 13–20.
7. ↵
   1. Tator CH,
   2. Fehlings MG

   (1991) Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75, 15–26.
8. ↵
   1. Guo T,
   2. Zhang L,
   3. Konermann A,
   4. Zhou H,
   5. Jin F,
   6. Liu W

   (2015) Manganese superoxide dismutase is required to maintain osteoclast differentiation and function under static force. Sci Rep 5, 8016.
9. ↵
   1. Sani M,
   2. Sebai H,
   3. Ghanem-Boughanmi N,
   4. Boughattas NA,
   5. Ben-Attia M

   (2015) Circadian (about 24-hour) variation in malondialdehyde content and catalase activity of mouse erythrocytes. Redox Rep 20, 26–32.
10. ↵
    1. Mao L,
    2. Wang H,
    3. Wang X,
    4. Liao H,
    5. Zhao X

    (2011) Transcription factor Nrf2 protects the spinal cord from inflammation produced by spinal cord injury. J Surg Res 170, e105–e115.
11. ↵
    1. Dolgun H,
    2. Sekerci Z,
    3. Turkoglu E,
    4. Kertmen H,
    5. Yilmaz ER,
    6. Anlar M,
    7. et al.

    (2010) Neuroprotective effect of mesna (2-mercaptoethane sulfonate) against spinal cord ischemia/reperfusion injury in rabbits. J Clin Neurosci 17, 486–489.
12. ↵
    1. Rothwell N

    (2003) Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential. Brain Behav Immun 17, 152–157.
13. ↵
    1. Valdearcos M,
    2. Robblee MM,
    3. Benjamin DI,
    4. Nomura DK,
    5. Xu AW,
    6. Koliwad SK

    (2014) Microglia dictate the impact of saturated fat consumption on hypothalamic inflammation and neuronal function. Cell Rep 9, 2124–2138.
14. ↵
    1. Harrington JF,
    2. Messier AA,
    3. Levine A,
    4. Szmydynger-Chodobska J,
    5. Chodobski A

    (2005) Shedding of tumor necrosis factor type 1 receptor after experimental spinal cord injury. J Neurotrauma 22, 919–928.
15. ↵
    1. Lu K,
    2. Cho CL,
    3. Liang CL,
    4. Chen SD,
    5. Liliang PC,
    6. Wang SY,
    7. et al.

    (2007) Inhibition of the MEK/ERK pathway reduces microglial activation and interleukin-1-beta expression in spinal cord ischemia/reperfusion injury in rats. J Thorac Cardiovasc Surg 133, 934–941.
16. ↵
    1. Akuzawa S,
    2. Kazui T,
    3. Shi E,
    4. Yamashita K,
    5. Bashar AH,
    6. Terada H

    (2008) Interleukin-1 receptor antagonist attenuates the severity of spinal cord ischemic injury in rabbits. J Vasc Surg 48, 694–700.
17. ↵
    1. Marini H,
    2. Altavilla D,
    3. Bellomo M,
    4. Adamo EB,
    5. Marini R,
    6. Laureanti F,
    7. et al.

    (2004) Modulation of IL-1 beta gene expression by lipid peroxidation inhibition after kainic acid-induced rat brain injury. Exp Neurol 188, 178–186.